DALLAS, May 17, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring BioSphere Medical Inc. (Nasdaq:BSMD). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
The full report is available at: www.microstockprofit.com/ads/BSMD
BioSphere Medical Inc. (BSMD) develops, markets and manufactures products for medical procedures, which uses embolotherapy. Embolotherapy is the minimally invasive, image-guided therapeutic introduction of various biocompatible substances into a patient's circulatory system to occlude a blood vessel, either to arrest or prevent hemorrhaging, or to devitalize or destroy the structure by occluding its blood supply. The technologies consist of bioengineered polymers, which are chemical compounds created through the application of medical science, engineering principles and manufacturing methods. As of December 31, 2009, the Company marketed and sold four microsphere products: EmboSphere Microspheres, EmboGold Microspheres, HepaSphere Microspheres and QuadraSphere Microspheres.
Message Board Search for BSMD: http://www.boardcentral.com/boards/BSMD
In the report, the analyst notes:
"Total worldwide revenue for the first quarter of 2010 was $7.12 million, compared with $7.28 million in the first quarter of 2009, a decline of 2%. Total revenue in the first quarter of this year includes $0.08 million from Nippon Kayaku, the Company's distribution partner in Japan.
"BSMD - the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy - recently reported that it has entered into an a definitive agreement and plan of merger with Merit Medical Systems, Inc. and Merit BioAcquisition Co., a wholly owned subsidiary of Merit Medical pursuant to which BSMD will merge with and into Merit BioAcquisition Co. in a cash transaction valued at approximately $96 million."
To read the entire report visit: www.microstockprofit.com/ads/BSMD
See what investors are saying about BSMD at penny stock forum
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com.
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.